Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BIO Critical Of PCORI’s Timing, Lack Of Specificity In National Priorities And Research Agenda

This article was originally published in The Pink Sheet Daily

Executive Summary

Biotechnology Industry Organization calls for research emphasis on health care systems and delivery of health care during a stakeholder feedback session hosted by the Patient-Centered Outcomes Research Institute.

You may also be interested in...



PCORI’s Selby Expects More Drug-Related Comparative Research In 2014

Research involving drugs has been limited since the Patient-Centered Outcomes Research Institute began project funding, but institute Executive Director Joe Selby expects that to change as PCORI prepares to issue funding announcements for pragmatic trials.

PCORI Will Fund 50 Pilot Project Grants To Bolster Research Foundation

The Patient-Centered Outcomes Research Institute will allot $30 million in grants to improve methodologies and help build the foundation for its research.

PhRMA, BIO Recommendations To PCORI Emphasize Studying Delivery Of Care Rather Than Comparing Products

The Pharmaceutical Research and Manufacturers of America and the Biotechnology Industry Organization target data on health care delivery in their recommendations for what the Patient-Centered Outcomes Research Institute should focus its attention on.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS073815

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel